NO20031739D0 - Fremgangsmåte for rensing av plavastatin - Google Patents

Fremgangsmåte for rensing av plavastatin

Info

Publication number
NO20031739D0
NO20031739D0 NO20031739A NO20031739A NO20031739D0 NO 20031739 D0 NO20031739 D0 NO 20031739D0 NO 20031739 A NO20031739 A NO 20031739A NO 20031739 A NO20031739 A NO 20031739A NO 20031739 D0 NO20031739 D0 NO 20031739D0
Authority
NO
Norway
Prior art keywords
plavastatin
purifying
purifying plavastatin
Prior art date
Application number
NO20031739A
Other languages
English (en)
Other versions
NO20031739L (no
Inventor
Nobunari Sugio
Shunshi Kojima
Yasuyuki Takamatsu
Minoru Hagisawa
Kiyoshi Hamano
Mutsuo Suzuki
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18794392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031739(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20031739D0 publication Critical patent/NO20031739D0/no
Publication of NO20031739L publication Critical patent/NO20031739L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/58—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/60—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20031739A 2000-10-16 2003-04-15 Fremgangsmåte for rensing av pravastatin NO20031739L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000315256A JP3236282B1 (ja) 2000-10-16 2000-10-16 プラバスタチンを精製する方法
PCT/JP2001/009045 WO2002032848A1 (fr) 2000-10-16 2001-10-15 Procede de purification de pravastatine

Publications (2)

Publication Number Publication Date
NO20031739D0 true NO20031739D0 (no) 2003-04-15
NO20031739L NO20031739L (no) 2003-06-13

Family

ID=18794392

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031739A NO20031739L (no) 2000-10-16 2003-04-15 Fremgangsmåte for rensing av pravastatin

Country Status (19)

Country Link
US (1) US20030216596A1 (no)
EP (4) EP1514863A1 (no)
JP (1) JP3236282B1 (no)
KR (1) KR20030042018A (no)
CN (4) CN1690037A (no)
AU (1) AU2001294258A1 (no)
BR (1) BR0114681A (no)
CA (1) CA2425883A1 (no)
CZ (1) CZ20031052A3 (no)
HU (1) HUP0303106A3 (no)
IL (1) IL155360A0 (no)
MX (1) MXPA03003347A (no)
NO (1) NO20031739L (no)
NZ (3) NZ536891A (no)
PL (1) PL360934A1 (no)
RU (2) RU2260582C2 (no)
SK (1) SK4532003A3 (no)
WO (1) WO2002032848A1 (no)
ZA (1) ZA200302966B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW589178B (en) * 2003-02-21 2004-06-01 China Chemical & Pharmaceutica A novel industrial process to obtain pravastatin sodium of high purity
EP1452519A1 (en) * 2003-02-25 2004-09-01 Balkanpharma-Razgrad AD Method for the isolation and purification of pravastatin sodium
US20090042979A1 (en) * 2004-08-06 2009-02-12 Transform Pharmaceuticals Inc. Novel Statin Pharmaceutical Compositions and Related Methods of Treatment
JP2008509154A (ja) * 2004-08-06 2008-03-27 トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド 新規なスタチン薬剤組成物および関連治療方法
AU2005271407A1 (en) * 2004-08-06 2006-02-16 Transform Pharmaceuticals, Inc. Novel fenofibrate formulations and related methods of treatment
CN100361954C (zh) * 2005-05-16 2008-01-16 天津市冠东科技有限公司 制备普伐他汀结晶体的干燥方法
JP4813841B2 (ja) * 2005-07-25 2011-11-09 キユーピー株式会社 プラバスタチンナトリウムの製造方法
AU2009308707A1 (en) * 2008-10-31 2010-05-06 Biogen Idec Ma Inc. LIGHT targeting molecules and uses thereof
CN109796333B (zh) * 2019-01-25 2021-04-09 北大方正集团有限公司 一种从发酵液中提取纯化普伐他汀钠的方法
CN112778120B (zh) * 2019-11-08 2024-05-17 上海现代制药股份有限公司 一种降血脂类药物氧化杂质的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd ３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
US5202029A (en) * 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
WO1997006128A1 (en) * 1995-08-03 1997-02-20 Gist-Brocades B.V. Selective process for the deacylation of acylated compounds
SI20305A (sl) * 1999-08-06 2001-02-28 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristali natrijeve soli pravastatina
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
JP3737801B2 (ja) * 2000-10-05 2006-01-25 テバ ジョジセルジャール レースベニュタールシャシャーグ プラバスタチンラクトン及びエピプラバスタチンを実質的に含まないプラバスタチンナトリウム、並びにそれを含む組成物

Also Published As

Publication number Publication date
EP1522589A1 (en) 2005-04-13
EP1327626A1 (en) 2003-07-16
PL360934A1 (en) 2004-09-20
MXPA03003347A (es) 2003-06-19
NZ536892A (en) 2005-05-27
HUP0303106A2 (hu) 2003-12-29
EP1327626A4 (en) 2004-08-18
CN1481353A (zh) 2004-03-10
CN1679535A (zh) 2005-10-12
CZ20031052A3 (cs) 2003-09-17
RU2260582C2 (ru) 2005-09-20
KR20030042018A (ko) 2003-05-27
SK4532003A3 (en) 2003-10-07
RU2005113661A (ru) 2006-11-10
EP1514863A1 (en) 2005-03-16
AU2001294258A1 (en) 2002-04-29
NO20031739L (no) 2003-06-13
BR0114681A (pt) 2003-12-09
WO2002032848A1 (fr) 2002-04-25
CN1868996A (zh) 2006-11-29
EP1514862A1 (en) 2005-03-16
IL155360A0 (en) 2003-11-23
CN1690037A (zh) 2005-11-02
JP3236282B1 (ja) 2001-12-10
ZA200302966B (en) 2004-07-15
HUP0303106A3 (en) 2004-10-28
NZ525256A (en) 2005-01-28
NZ536891A (en) 2005-05-27
JP2002121174A (ja) 2002-04-23
US20030216596A1 (en) 2003-11-20
CA2425883A1 (en) 2003-04-15

Similar Documents

Publication Publication Date Title
NO20030241D0 (no) Fremgangsmåte for behandling av multiple brönnintervaller
EE200100475A (et) Gaaside desulfureerimise meetod
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20011121D0 (no) FremgangsmÕte for formasjonsbehandling med deformerbare partikler
IS6521A (is) Aðferð til að hreinsa gerjunarseyði
NO20022510D0 (no) Fremgangsmåte for sammenkopling av rör
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
NO20023549D0 (no) Fremgangsmåte for rensing av 1,2-dikloretan
NO20032822D0 (no) Fremgangsmåte for konsentrering av brukt syre
NO20032591D0 (no) Fremgangsmåte for isolering og rensing av epotiloner
NO20031739D0 (no) Fremgangsmåte for rensing av plavastatin
NO20043623L (no) Fremgangsmate for fremstilling av papir
IS6036A (is) Örveruaðferð við að framleiða pravastatín
NO20015162D0 (no) Fremgangsmåte for behandling av nevrodegenerering
FI20000325A0 (fi) Menetelmä rakenteen rasituksen määrittämiseksi
NO20032563D0 (no) Filtreringsfremgangsmåte
NO20031738L (no) Fremgangsmåte for rensing av pravastatin eller dets farmakologisk akseptable salt
NO20031197L (no) Rensing av naturlige hydrokarboner
NO20011056L (no) Fremgangsmate for utvelging av stivelse
NO20001985L (no) FremgangsmÕte for forming av strimmelformede folier
DK1311260T3 (da) Lipaseinhibitorer til behandling af dyspepsi
NO20034657D0 (no) Fremgangsmåte for rensing av en diolefinström
NO20015625L (no) Fremgangsmåte for reduksjon av NOx
NO20003779D0 (no) Rensing
NO20010444D0 (no) Anordning for rensing av vann

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application